Brief: Targovax: Sotio Stops Collaboration Trial With Dendritic Cell Vaccine DCVAC In Combination With ONCOS-102

Circio Holding ASA

09/02/2021 07:04

Feb 9 (Reuters) - Targovax ASA  TRVX.OL :
    * SOTIO HAS STOPPED COLLABORATION TRIAL WITH THE DENDRITIC
CELL
VACCINE DCVAC IN COMBINATION WITH ONCOS-102
    * COLLABORATION PARTNER SOTIO HAS STOPPED COMBINATION TRIAL
ASSESSING COMBINATION OF ONCOS-102 AND DCVAC/PCA IN PROSTATE
CANCER
    * RECRUITMENT COULD NOT MEET ORIGINALLY PLANNED NUMBERS.
    * DECISION WILL NOT IMPACT FURTHER DEVELOPMENT OF ONCOS-102.

Source text for Eikon:  ID:nWkr4H8yMx 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))